This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Conmed Corp (CNMD)

NASDAQ: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 719.17M 740.05M 762.70M 767.14M
Cost of Sales 293.59M 290.26M 302.42M 314.68M
Gross Operating Profit 425.58M 444.20M 454.33M 452.46M
Selling, General, and Administrative Expenses 303.09M 293.94M 310.73M 312.42M
Research & Development 27.44M 27.78M 25.83M 28.21M
Operating Income before D & A (EBITDA) 95.05M 122.48M 117.77M 111.83M
Depreciation & Amortization 43.88M 45.73M 47.87M 46.62M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 0.00 -23.96M -13.66M 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 51.17M 52.79M 56.24M 65.21M
Interest Expense 6.03M 6.11M 5.61M 5.73M
Pre-Tax Income 45.14M 46.67M 50.63M 59.48M
Income Taxes 14.65M 14.48M 14.69M 19.00M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 30.50M 32.19M 35.94M 40.48M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 30.50M 32.19M 35.94M 40.48M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 30.50M 32.19M 35.94M 40.48M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
30.50M 32.19M 35.94M 40.48M
Preferred Dividends
Net Income Available To Common 30.50M 32.19M 35.94M 40.48M
Basic EPS from Continuing Ops. 1.10 1.17 1.30 1.43
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.10 1.17 1.30 1.43
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.10 1.17 1.30 1.43
Basic Normalized Net Income/Share 1.10 1.17 1.30 1.43
EPS fr Continuing Ops. 1.09 1.16 1.28 1.41
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.09 1.16 1.28 1.41
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.09 1.16 1.28 1.41
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.09 1.16 1.28 1.41
Dividends Paid per Share 0.80 0.80 0.65 0.60
CNMD News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for CNMD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 1 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CNMD ANALYST REPORT

CNMD Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs